Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2024. The list includes several groundbreaking therapies that are expected to change the ...

A procalcitonin-guided algorithm does not reduce the length of intravenous antibiotic treatment significantly in children ...

An 11-year-old boy overcomes Guillain-Barré syndrome, a rare neurological disorder, with timely treatment, intensive care, ...